On July 22, 2025, MNG delivered a letter (the "Letter") to the Board of Directors of the Issuer (the "Board") setting forth a non-binding offer to acquire all of the issued and outstanding shares of the Issuer's Series A Common Stock and the Issuer's Series B common stock, par value $0.01 per share ("Series B Common Stock" and, together with the Series A Common Stock, "Common Stock") not already owned by MNG for $16.50 per share in cash (the "Proposal"), on the terms and subject to the conditions set forth in the Letter. The Proposal is not subject to any financing conditions, but it remains subject to MNG's satisfactory completion of due diligence and the negotiation and execution of definitive documentation. Accordingly, the terms and conditions set forth in the Proposal are subject to change. The Proposal is a non-binding expression of interest only, and it does not constitute an offer capable of acceptance or a legally binding obligation. MNG reserves the right to withdraw or modify the Proposal at any time. The Letter and the Proposal (1) are intended solely for the consideration of the Board and not for the consideration of the Issuer's shareholders or any other person or entity, and (2) are not, and are not intended to be, a solicitation of a proxy or vote with respect to any securities of the Issuer or any other securities, or an offer to purchase or a solicitation of an offer to sell any securities of the Issuer or any other securities. As of the date of this Schedule 13D, the Board has not responded to the Proposal. The Reporting Persons intend to respond to inquiries from, and, if invited, engage in discussions and negotiations concerning the Proposal with the Board and the Issuer and its officers, advisors, and other representatives. There can be no certainty or guarantee as to whether any such discussions or negotiations will occur, or, if they occur, the outcome thereof. The Reporting Persons may enter into confidentiality or similar agreements with the Issuer to facilitate such discussions and negotiations. The Reporting Persons intend to review their investment in the Issuer on a continuing basis and may, at any time and from time to time, take such actions with respect to the investment as they deem appropriate, depending on various factors, including, without limitation: (1) the outcome of any discussions or negotiations referenced in this Schedule 13D; (2) the outcome of any negotiations between the Issuer and any other potential acquirer of the Issuer; (3) the Issuer's financial position and strategic direction; (4) actions taken by or at the direction of the Board; (5) market prices for the Issuer's securities; (6) other investment opportunities available to the Reporting Persons; (7) general securities market and financing market conditions; and (8) general economic and industry conditions. Such actions may involve: (1) acquiring additional Common Stock or other equity, debt, notes, securities or instruments, or derivative or other instruments that are based upon or relate to the value of securities or instruments, of the Issuer (collectively, "Securities"), in the open market or otherwise; (2) disposing of any or all of their Securities, in the open market or otherwise; (3) engaging in hedging or similar transactions with respect to the Securities; or (4) proposing, planning, or considering one or more of the actions described in subsections (a) through (j) of Item 4 of Schedule 13D. If entered into and consummated, the transactions contemplated by the Letter and the Proposal, or any other similar transaction, would, among other things: (1) result in the Reporting Persons' acquisition of additional securities of the Issuer; (2) effectuate a merger of the Issuer; (3) effectuate a change of control of the Issuer; (4) result in changes to the Issuer's certificate of formation and bylaws; (5) result in changes to the board of directors or management of the Issuer; (6) lead to the delisting of the Series A Common Stock from The Nasdaq Stock Market; and (7) lead to the deregistration of the Series A Common Stock under the Securities Exchange Act of 1934, as amended. The foregoing descriptions of the Letter and the Proposal and the transactions contemplated thereby, are qualified in their entirety by reference to the full text of the Letter, a copy of which is included as Exhibit 3 to this Schedule 13D and is incorporated by reference in its entirety.